• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由流行病防范创新联盟(CEPI)集中实验室网络评估新冠疫苗的标准化免疫检测方法。

Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network.

作者信息

Azizi Ali, Ogbeni Deborah, Kamuyu Gathoni, Schwartz Lauren M, Clark Carolyn, Spencer Peter, Bernasconi Valentina

机构信息

CEPI, 1901 Pennsylvania Ave, NW #1003, Washington, DC, USA.

CEPI, Gibbs Building, 215 Euston Rd, Bloomsbury, London, UK.

出版信息

NPJ Vaccines. 2024 Jul 16;9(1):128. doi: 10.1038/s41541-024-00921-0.

DOI:10.1038/s41541-024-00921-0
PMID:39013875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11252371/
Abstract

The CEPI Centralized Laboratory Network implemented key steps in the transfer and monitoring of the developed immunological SARS-CoV-2 assays to ensure standardization across all the facilities of the network. This comprehensive evaluation reinforces the reliability of the generated data and establishes a solid foundation for a standardized approach, enabling precise inter-laboratory comparisons and contributing to the overall integrity of our network's clinical results. Herein, we will provide a brief elaboration on the specific measures and procedures implemented to standardize the transfer of assays across our network.

摘要

流行病防范创新联盟(CEPI)集中实验室网络在已开发的新冠病毒免疫检测方法的转移和监测方面采取了关键步骤,以确保网络内所有设施的标准化。这一全面评估加强了所生成数据的可靠性,并为标准化方法奠定了坚实基础,实现了精确的实验室间比较,有助于提升我们网络临床结果的整体完整性。在此,我们将简要阐述为使检测方法在我们网络中实现标准化转移而实施的具体措施和程序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/91e3116c837e/41541_2024_921_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/57d360ce9e06/41541_2024_921_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/fe345c4f64b9/41541_2024_921_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/91e3116c837e/41541_2024_921_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/57d360ce9e06/41541_2024_921_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/fe345c4f64b9/41541_2024_921_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/613f/11252371/91e3116c837e/41541_2024_921_Fig3_HTML.jpg

相似文献

1
Standardized immunological assays for assessing COVID-19 vaccines by the CEPI-Centralized Laboratory Network.由流行病防范创新联盟(CEPI)集中实验室网络评估新冠疫苗的标准化免疫检测方法。
NPJ Vaccines. 2024 Jul 16;9(1):128. doi: 10.1038/s41541-024-00921-0.
2
Driving consistency: CEPI-Centralized Laboratory Network's conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines.推动一致性:CEPI-集中实验室网络的 SARS-CoV-2 临床检测转换因子倡议,用于评估 COVID 疫苗的疗效。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344249. doi: 10.1080/21645515.2024.2344249. Epub 2024 May 6.
3
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.CEPI集中实验室网络在疫苗临床试验中使用的抗SARS-CoV-2免疫反应标准化定量检测方法:一项鉴定分析。
Lancet Microbe. 2024 Mar;5(3):e216-e225. doi: 10.1016/S2666-5247(23)00324-5. Epub 2024 Jan 23.
4
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization.COVID-19 的血清学科学网络(SeroNet):血清学检测的深度和广度,以及检测协调计划。
mSphere. 2022 Aug 31;7(4):e0019322. doi: 10.1128/msphere.00193-22. Epub 2022 Jun 15.
5
Comparison of fifteen SARS-CoV-2 nucleic acid amplification test assays used during the Canadian Laboratory Response Network's National SARS-CoV-2 Proficiency Program, May 2020 to June 2021.2020年5月至2021年6月期间,加拿大实验室反应网络国家新型冠状病毒2019冠状病毒病能力验证计划中使用的15种新型冠状病毒2019冠状病毒病核酸扩增检测方法的比较。
Can Commun Dis Rep. 2023 May 1;49(5):180-189. doi: 10.14745/ccdr.v49i05a03.
6
Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines.追求有效 SARS-CoV-2(COVID-19)疫苗的进展与困境。
Front Immunol. 2020 Oct 2;11:579250. doi: 10.3389/fimmu.2020.579250. eCollection 2020.
7
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.CEPI/BC 2020 年 3 月 12-13 日会议共识总结报告:评估 COVID-19 疫苗引起疾病增强的风险。
Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25.
8
Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera.通过标准化病毒中和试验定量针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的绝对中和滴度,可实现2019冠状病毒病(COVID-19)血清的跨队列比较。
mBio. 2021 Feb 16;12(1):e02492-20. doi: 10.1128/mBio.02492-20.
9
Evolution of nucleic acid amplification testing across Canada as observed through the Canadian Laboratory Response Network's SARS-CoV-2 Proficiency Test Program, May 2020 to June 2021.2020年5月至2021年6月,通过加拿大实验室反应网络的SARS-CoV-2能力验证测试计划观察到的加拿大核酸扩增检测的演变情况。
Can Commun Dis Rep. 2023 May 1;49(5):175-179. doi: 10.14745/ccdr.v49i05a02.
10
The CEPI centralized laboratory network for COVID-19 will help prepare for future outbreaks.CEPI的COVID-19集中实验室网络将有助于为未来的疫情爆发做好准备。
Nat Med. 2023 Nov;29(11):2684-2685. doi: 10.1038/s41591-023-02534-x.

引用本文的文献

1
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers.针对慢性传染病的治疗性疫苗综述:人乳头瘤病毒和爱泼斯坦-巴尔病毒相关癌症治疗性疫苗的评估体系
Hum Vaccin Immunother. 2025 Dec;21(1):2457187. doi: 10.1080/21645515.2025.2457187. Epub 2025 Feb 16.
2
Preparedness and priority research to tackle the mpox outbreak response.应对猴痘疫情的准备工作和重点研究。
Nat Med. 2025 Jan;31(1):14-15. doi: 10.1038/s41591-024-03367-y.

本文引用的文献

1
Driving consistency: CEPI-Centralized Laboratory Network's conversion factor initiative for SARS-CoV-2 clinical assays used for efficacy assessment of COVID vaccines.推动一致性:CEPI-集中实验室网络的 SARS-CoV-2 临床检测转换因子倡议,用于评估 COVID 疫苗的疗效。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344249. doi: 10.1080/21645515.2024.2344249. Epub 2024 May 6.
2
Unifying global efforts by CEPI's centralized laboratory network.通过流行病防范创新联盟(CEPI)的集中实验室网络统一全球努力。
Front Immunol. 2024 Apr 11;15:1404309. doi: 10.3389/fimmu.2024.1404309. eCollection 2024.
3
Standardised quantitative assays for anti-SARS-CoV-2 immune response used in vaccine clinical trials by the CEPI Centralized Laboratory Network: a qualification analysis.
CEPI集中实验室网络在疫苗临床试验中使用的抗SARS-CoV-2免疫反应标准化定量检测方法:一项鉴定分析。
Lancet Microbe. 2024 Mar;5(3):e216-e225. doi: 10.1016/S2666-5247(23)00324-5. Epub 2024 Jan 23.
4
The CEPI centralized laboratory network for COVID-19 will help prepare for future outbreaks.CEPI的COVID-19集中实验室网络将有助于为未来的疫情爆发做好准备。
Nat Med. 2023 Nov;29(11):2684-2685. doi: 10.1038/s41591-023-02534-x.
5
The CEPI centralised laboratory network: supporting COVID-19 vaccine development.流行病防范创新联盟(CEPI)集中实验室网络:支持新冠疫苗研发
Lancet. 2021 Jun 5;397(10290):2148-2149. doi: 10.1016/S0140-6736(21)00982-X.
6
WHO Expert Committee on Specifications for Pharmaceutical Preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 2011(961):1-428, back cover.